Sagility

Quick check

The five things to look at first. Open one for more.

• DebtModerate safety, with cautionRated A to BBB+ by 2 agencies.
• ResultsGrowingIn the Sep 2026 quarter, sales rose 23% and profit rose 13% from a year earlier.
• DilutionNo new sharesNo new shares issued in the last year, so existing shareholders' slices were not cut.
• PromotersPromoters sellingThe promoters (founders or parent) own 51%, down from 67% in Sep 2025.
• ValuationCheap vs its pastThe share trades at 19.5 times its yearly earnings (P/E), cheaper than 98% of the time in the last 2 years. Its usual P/E is about 31.

Sagility against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.

• Valuation (P/E)19.5 against a typical 24.9: cheaper than most peers (1st = cheapest).44th of 106
• Sales growth+22.6% against a typical +20.8% from a year earlier.41st of 85
• Profit growth+13.1% against a typical +5.6% from a year earlier.37th of 77
• Share price, 3 months+2.7% against a typical −11.2%.27th of 93
• Size₹ 20,644.7 Cr. market value against a typical ₹ 206.6 Cr. (1st = largest).5th of 100

Exchange filings and their impact on the company.

• 22 Oct 2026DividendLow impactPositivePrice −2.7% on 23 Oct
  Board declared Rs 0.15 interim dividend, a small ~Rs 70 cr cash return.

  Sagility's board on October 22, 2026 declared an interim dividend of Rs 0.15 per Rs 10 share for FY27. The record date is October 30, 2026 and payment is due on or before November 21, 2026. At ~467.9 crore shares this is about Rs 70 crore payout, a modest return reflecting healthy cash generation.

  Full analysisFiling
• 22 Oct 2026Outcome of Board MeetingHigh impactVery positivePrice −2.7% on 23 Oct
  Strong Q2 with 22.5% revenue growth, 6-quarter high margin and tripled interim dividend.

  Sagility reported strong Q2 FY27 results with revenue of Rs 2032.1 crore, up 22.5% year-on-year, adjusted EBITDA of Rs 535.3 crore at 26.3% margin and adjusted profit of Rs 325.4 crore. For the first half, revenue was Rs 3995.6 crore, up 25%, with 28 new client groups added and $40.2 million of new business won. The Board also declared an interim dividend of Rs 0.15 per share, up from Rs 0.05 last time, with record date October 30, 2026.

  Full analysisFiling
• 21 Oct 2026General UpdatesLow impactPositivePrice +2.2% on 22 Oct
  Sagility signed a deal to acquire US-based Chirok Health to expand its provider business.

  Sagility Limited said its wholly owned US subsidiary Sagility (US) Holdings Inc. signed a definitive agreement on 21 October 2026 to acquire Chirok Health LLC. No deal value, financials or closing timeline were disclosed in the filing. The acquisition is aimed at accelerating Sagility's provider growth strategy in the US healthcare market.

  Full analysisFiling

Results dates and other board meetings. Full calendar

Compounded yearly rates over each period.

Listed companies in the same business.

Ramesh Gopalan

Chief Executive Officer, Managing Director

Satishkumar Sakharayap Seetharamaiah

Compliance Officer, Company Secretary